Physiology and biochemistry: the heart of bioenergetics
Coenzyme Q10 (CoQ10), also known as ubiquinone, is a molecule located within the inner mitochondrial membrane, where it acts as the main mobile electron carrier. Chemically, it is a fat-soluble benzoquinone whose structure provides the hydrophobicity necessary to move freely within the phospholipid bilayer, protecting cellular structures and circulating lipoproteins from free radical attack.
Its primary role is carried out in the electron transport chain (ETC), the biochemical system responsible for oxidative phosphorylation and the subsequent generation of adenosine triphosphate (ATP). Without optimal CoQ10 saturation in the mitochondria, energy efficiency declines drastically, compromising tissues with high metabolic demands such as the myocardium and neuronal tissue. In addition to its bioenergetic function, CoQ10 is the only fat-soluble antioxidant that the body is able to synthesize autonomously and actively regenerate after oxidation.
There are two main forms of the molecule: ubiquinone (oxidized form) and ubichinol (reduced form). In its reduced form, CoQ10 exerts a powerful scavenging action against free radicals, protecting mitochondrial membranes and low-density lipoproteins (LDL) from lipid peroxidation, thus safeguarding the integrity of mitochondrial DNA.
Ubiquinone vs Ubichinol: the bioavailability dilemma
The distinction between ubiquinone and ubichinol is of fundamental clinical importance for optimizing nutritional supplementation. In a young and healthy organism, a dedicated enzyme system constantly converts ubiquinone into ubichinol. However, with advancing age or in the presence of chronic pathological conditions characterized by high oxidative stress, the efficiency of this enzymatic conversion declines significantly, creating a metabolic bottleneck.
Ubichinol represents approximately 90-95% of the total CoQ10 circulating in human plasma. From a pharmacokinetic standpoint, several clinical studies have shown that ubichinol has a superior absorption capacity, increasing plasma levels more efficiently than the oxidized form at the same dosage. This superiority is linked to its greater relative hydrophilicity, which facilitates its incorporation into intestinal micelles.
┌────────────────────────────────────────────────────────┐│ STATINS AND COQ10 DEPLETION │├─────────────────────────┬──────────────────────────────┤│ Biochemical Step │ HMG-CoA Reductase ││ Effect of Statins │ Blocked by the drug ││ Consequence on CoQ10 │ Primary synthesis interrupted│├─────────────────────────┼──────────────────────────────┤│ Mevalonate Intermediate │ Significant reduction ││ Consequence on CoQ10 │ Missing substrate for CoQ10 │├─────────────────────────┼──────────────────────────────┤│ Farnesyl-Pyrophosphate │ Decrease ││ Consequence on CoQ10 │ Lack of isoprenoid building blocks│├─────────────────────────┼──────────────────────────────┤│ Clinical Result │ Cholesterol drop ││ Consequence on CoQ10 │ Myopathy and chronic fatigue│└─────────────────────────┴──────────────────────────────┘Clinical areas of application
The therapeutic use of CoQ10 finds wide support in several areas of specialist medicine:
· Cardiology: The myocardium has the highest concentration of mitochondria per cell in the body. Major clinical trials, such as the Q-SYMBIO trial, have shown that CoQ10 supplementation in patients with chronic heart failure contributes to a significant reduction in cardiovascular mortality and hospitalization rates. Furthermore, CoQ10 is widely studied for countering muscle symptoms associated with statin use (SAMS). Statins, by blocking the mevalonate pathway to inhibit cholesterol synthesis, simultaneously inhibit the production of farnesyl pyrophosphate, an essential precursor of the CoQ10 side chain, leading to potential cases of myopathy and asthenia.
· Neurology: Thanks to its ability to cross the blood-brain barrier in highly bioavailable formulations, CoQ10 exerts a neuroprotective action, proving useful in countering oxidative damage in neurodegenerative diseases such as Parkinson's disease.
· Fertility: It plays a leading role in supporting the oocyte energy reserve, countering mitochondrial decline linked to maternal age.
· Chronic fatigue syndromes and fibromyalgia: Optimizing tissue levels of CoQ10 is associated with a reduction in pain perception and an improvement in cognitive alertness.
Synergies and intake protocols
The effectiveness of supplementation is strictly dependent on synergy with other biochemical cofactors:
· Vitamin E (alpha-tocopherol): It works in tandem with CoQ10 to protect cell membranes. Ubichinol actively regenerates vitamin E after it has neutralized a free radical, preserving overall antioxidant defenses.
· Selenium: It acts as an essential cofactor of thioredoxin reductase, the key enzyme responsible for reducing CoQ10 from ubiquinone to ubichinol within tissues. Without an adequate supply of selenium, the effectiveness of CoQ10 supplementation may be compromised.
Regarding administration methods, the lipophilic nature of the molecule requires intake with a meal containing an adequate lipid portion (at least 5-10 grams of fat) to stimulate bile secretion and the formation of mixed micelles, improving intestinal absorption.
Drug interactions
In addition to the known depletion induced by statins, attention should be paid to patients on oral anticoagulant therapy (such as vitamin K antagonists). Structurally similar to vitamin K, CoQ10 could theoretically interfere with INR values, requiring constant monitoring of prothrombin time. Conversely, prolonged use of beta-blockers or tricyclic antidepressants can reduce the endogenous biosynthesis of CoQ10, justifying targeted nutritional support.
NOTE: The information in the product sheets on this site is for informational and educational purposes only and does not represent medical advice. The published content is not intended to replace the relationship with a doctor or any medical indications, diagnoses, or prescriptions. The reported information describes the ingredients and characteristics of food supplements, designed as support for the balance and well-being of the body within a healthy lifestyle. Food supplements are not medicines and must not be used to prevent, diagnose, treat, or alleviate diseases or pathological conditions.
PRODUCT_ITEM
Bibliographic References
1. Hosoe M, Kitano M, Kishida F, et al. Study on safety and bioavailability of ubiquinol (reduced coenzyme Q10) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol. 2007;47(1):19-28.
2. Mortensen SA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014;2(6):641-649.
3. Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. 2002;59(10):1541-1550.
4. Cordero MD, Alcocer-Gómez E, de Miguel M, et al. Can coenzyme q10 improve clinical symptoms in fibromyalgia?. Antioxid Redox Signal. 2013;19(12):1356-1361.
5. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A. 1989;86(16):6377-6381.
6. Bjørklund G, Chirumbolo S, Dadar M, et al. Selenium and coenzyme Q10 in cardiovascular health. Biomolecules. 2020;10(4):570.
7. Miles LF, Morrow JD, et al. Bioavailability of coenzyme Q10: a review of absorption and pharmacokinetics. Nutr Res Rev. 2005;18(2):153-162.
8. Folkers K, Stollenwerk R, Takemura K. Bioenergetics in clinical medicine. XVI. Reduction of coenzyme Q10 levels in patients treated with beta-blockers and other drugs. Proc Natl Acad Sci U S A. 1990;87(12):4537-4541.
